PD-L1 Amplified Tumor (9p24.1)
2 clinical trials · Condition
◉ Watch PD-L1 Amplified Tumor (9p24.1)
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors (NCT04272034) | Incyte Corporation | 2021-03-26 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors (NCT04242199) | Incyte Corporation | 2020-09-04 |
Track PD-L1 Amplified Tumor (9p24.1) automatically
Every clearance here is in the API, with alerts when new ones post.